Lipophilicity and biomimetic properties to support drug discovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lipophilicity and biomimetic properties to support drug discovery

Published:2017-06-28 Issue:9 Volume:12 Page:885-896
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Tsopelas Fotios¹,Giaginis Constantinos²,Tsantili-Kakoulidou Anna³

Affiliation:

1. Laboratory of Inorganic and Analytical Chemistry, School of Chemical Engineering, National Technical University of Athens, Athens, Greece

2. Department of Food Science and Nutrition, School of Environment, University of the Aegean, Myrina, Lemnos, Greece

3. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2017.1344210

Reference143 articles.

1. Drug Design and Discovery

2. Multitasking models for quantitative structure–biological effect relationships: current status and future perspectives to speed up drug discovery

3. How to improve R&D productivity: the pharmaceutical industry's grand challenge

4. Pharmacokinetic Challenges in Lead Optimization

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immobilised artificial membrane liquid chromatography vs liposome electrokinetic capillary chromatography: Suitability in drug/bio membrane partitioning studies and effectiveness in the assessment of the passage of drugs through the respiratory mucosa;Journal of Chromatography A;2024-10

2. PharmaBench: Enhancing ADMET benchmarks with large language models;Scientific Data;2024-09-10

3. Synthesis and cytotoxicity of copper(II) semicarbazone complexes with lipophilic counter-anions;Inorganica Chimica Acta;2024-09

4. Discovery of ZJCK-6-46: A Potent, Selective, and Orally Available Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor for the Treatment of Alzheimer’s Disease;Journal of Medicinal Chemistry;2024-07-23

5. Contribution of lipophilicity to the clinical effects of drugs;Russian Journal of Cardiology;2024-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3